| ZEMANOVÁ, Milada, Luboš PETRUZELKA, Petr ZATLOUKAL, Miloš PEŠEK, Ivona GRYGÁROVÁ, Jana SKŘIČKOVÁ, Adam SVOBODNÍK a David VRÁNA. Gefitinib toxicity has been significantly correlated with survival in non-small cell lung cancer patients treated in EAP program in Czech Republic. In Journal of Thoracic Oncology. Seoul, Korea: ERS, 2007, s. 748-748. ISSN 1556-0864. |
Další formáty:
BibTeX
LaTeX
RIS
@inproceedings{724772,
author = {Zemanová, Milada and Petruzelka, Luboš and Zatloukal, Petr and Pešek, Miloš and Grygárová, Ivona and Skřičková, Jana and Svobodník, Adam and Vrána, David},
address = {Seoul, Korea},
booktitle = {Journal of Thoracic Oncology},
keywords = {Gefitinib; toxicity; non-small cell lung cancer;survival},
language = {eng},
location = {Seoul, Korea},
pages = {748-748},
publisher = {ERS},
title = {Gefitinib toxicity has been significantly correlated with survival in non-small cell lung cancer patients treated in EAP program in Czech Republic},
year = {2007}
}
TY - JOUR
ID - 724772
AU - Zemanová, Milada - Petruzelka, Luboš - Zatloukal, Petr - Pešek, Miloš - Grygárová, Ivona - Skřičková, Jana - Svobodník, Adam - Vrána, David
PY - 2007
TI - Gefitinib toxicity has been significantly correlated with survival in non-small cell lung cancer patients treated in EAP program in Czech Republic
PB - ERS
CY - Seoul, Korea
KW - Gefitinib
KW - toxicity
KW - non-small cell lung cancer;survival
N2 - Toxicity of the anti-tumour drug, Gefitinib, has been followed up in a multi-center study of non-small cell lung cancer and correlated with patients' survival. The results in the Czech leg of the study have suggested a significant correlation.
ER -
ZEMANOVÁ, Milada, Luboš PETRUZELKA, Petr ZATLOUKAL, Miloš PEŠEK, Ivona GRYGÁROVÁ, Jana SKŘIČKOVÁ, Adam SVOBODNÍK a David VRÁNA. Gefitinib toxicity has been significantly correlated with survival in non-small cell lung cancer patients treated in EAP program in Czech Republic. In \textit{Journal of Thoracic Oncology}. Seoul, Korea: ERS, 2007, s.~748-748. ISSN~1556-0864.
|
